Serial #79368065
LIVE

Serial Number

79368065

Owner

Rephine Limited

Attorney

Michael J. Brown

Filing Date

Nov 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79368065 Trademark

Serial Number: 79368065 • Registration: 7416490

Serial #79368065 is a trademark filed by Rephine Limited on November 18, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Rephine Limited (3 trademarks)

Unit 15a Meadway Court,

Entity Type: 99

Trademark Details

Filing Date

November 18, 2022

Registration Date

June 18, 2024

Published for Opposition

April 2, 2024

Goods & Services

Pharmaceutical product evaluation; quality audits in the nature of product quality evaluation in the field of pharmaceuticals; product quality control testing; product safety testing services in the field of pharmaceuticals; pharmaceutical manufacturing safety testing services; quality assurance consultancy in the field of pharmaceuticals and the manufacture of pharmaceuticals; technical inspection of pharmaceuticals and manufacturing processes for pharmaceuticals for quality control purposes; inspection of pharmaceuticals; quality control testing services; testing of pharmaceuticals; testing of pharmaceuticals of others to determine whether pharmaceuticals conform to quality certification standards; industrial analysis in the field of pharmaceuticals and manufacturing processes for pharmaceuticals; testing the medical products, pharmaceuticals, manufacturing systems, methods and processes of others to determine whether they conform to established accreditation, certification, regulatory and quality standards; software-as-a-service services featuring software for quality management systems, manufacturing systems, manufacturing methods and manufacturing processes; design and development of software for control, regulation and monitoring of quality management systems, manufacturing systems, methods and processes; scientific research in the nature of conducting clinical trials for others; scientific study protocol development; research and development for the pharmaceutical industry; information, advisory and consultancy services in relation to the aforesaid

Database management; market research by means of a computer database; compilation of information into computer databases; collating of data in computer databases; provision of commercial information from online databases; business information services provided online from a computer database or the internet; business information services; commercial information services; provision of business information; records management services, namely, document indexing for others; information, advisory and consultancy services in relation to the aforesaid

Regulatory compliance auditing; legal compliance auditing; legal services, namely, good manufacturing practices audit; advisory services relating to regulatory affairs; reviewing standards and practices to assure compliance with pharmaceutical laws and regulations; regulatory compliance consulting in the field of manufacturing standards; analysis of data, policy and process to ensure compliance with pharmaceutical laws and regulations; legal and regulatory compliance consulting services; legal and regulatory advisory and consultancy services in relation to clinical trials; provision of legal information and advice relating to quality, performance and regulatory systems; security threat analysis for the physical safety of goods and individuals; security due diligence services in the nature of verification of personal identity relating to physical safety and security for the protection of people and tangible property; providing information in the field of manufacturing facility physical security, namely, provision of benchmarking and reference information relating to safety standards; information, advisory and consultancy services in relation to the aforesaid

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 14, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 3, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 16, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 29, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 29, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 23, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 11, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 1, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 10, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 10, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 26, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 20, 2023 REPR